Last reviewed · How we verify
Rifampin daily for 16 weeks
Rifampin daily for 16 weeks is a Small molecule drug developed by Centers for Disease Control and Prevention. It is currently in Phase 2 development.
At a glance
| Generic name | Rifampin daily for 16 weeks |
|---|---|
| Sponsor | Centers for Disease Control and Prevention |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Shortened Regimen for Drug-susceptible TB in Children (PHASE3)
- Start4All - Start Taking Action for TB Diagnosis (DARE-TB) (NA)
- ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD) (PHASE2)
- Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Suppression (PHASE3)
- Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis (PHASE2)
- Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB (PHASE2)
- ATORvastatin in Pulmonary TUBerculosis (PHASE2)
- Evaluating a Shorter, Rifampicin-Based Treatment for People With Less Severe Tuberculosis Disease (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Rifampin daily for 16 weeks CI brief — competitive landscape report
- Rifampin daily for 16 weeks updates RSS · CI watch RSS
- Centers for Disease Control and Prevention portfolio CI
Frequently asked questions about Rifampin daily for 16 weeks
What is Rifampin daily for 16 weeks?
Rifampin daily for 16 weeks is a Small molecule drug developed by Centers for Disease Control and Prevention.
Who makes Rifampin daily for 16 weeks?
Rifampin daily for 16 weeks is developed by Centers for Disease Control and Prevention (see full Centers for Disease Control and Prevention pipeline at /company/centers-for-disease-control-and-prevention).
What development phase is Rifampin daily for 16 weeks in?
Rifampin daily for 16 weeks is in Phase 2.